Nephrology Dissertation Topics: Kidney, Dialysis and Transplant Ideas You Can Use
You have chosen nephrology, and now you need a question narrow enough to finish. Can you get the data, ethics approval and sources you need in the time you have? Does the question name a guideline, trial, registry or dataset rather than just a disease? Can you state one clear aim in a sentence? This page gives you nephrology dissertation topics to test those questions against. All topics, ideas and titles are 100% free.
Scope note: this page covers medical nephrology, meaning kidney disease, dialysis and transplant medicine. For surgical and urinary tract questions see our urology dissertation topics, and for diabetes and hormone questions see our endocrinology dissertation topics.
Position correct as of October 2026. Several areas below are still moving, including KDIGO guideline updates, drug approvals for glomerular disease and early xenotransplant studies. Where a topic depends on a live development, check the current position before you commit, and state its stage plainly in your proposal.
How to Choose a Nephrology Dissertation Topic
Start with the data route, not the disease. A secondary-data question using UK Kidney Association registry reports or NHS Blood and Transplant statistics can be finished without patient access. A question that needs interviews with dialysis patients needs ethics review, and often NHS approval, so allow extra months. Use the HRA decision tool to check whether your project counts as research, and check your own university’s rules on ethics and referencing.
If you are still comparing subjects, our guide on how to choose research topics helps, and the dissertation topic finder can suggest angles. Once you have a draft idea, shape it with our guide to writing a research question.
Chronic Kidney Disease and Risk Prediction Dissertation Topics
Chronic kidney disease (CKD) suits almost every level because large registries and trial reports are open to read. Pick a defined question, such as a single risk equation or a single guideline change.
1. How accurately does the Kidney Failure Risk Equation (KFRE) predict dialysis or transplant need in a UK primary care cohort compared with eGFR staging alone? Suits a secondary-data MSc if you can access routine records.
2. To what extent does the 2024 KDIGO CKD guideline’s heat-map risk classification change which patients a GP would refer to nephrology? A document and guideline analysis works at undergraduate level.
3. How far do eGFR equations that include or exclude race change CKD diagnosis rates in Black patients in published cohorts? A structured review is realistic here.
4. Whether combining cystatin C and creatinine improves eGFR accuracy in older adults: what does the published evidence show? Works as a systematic review.
5. What limits the uptake of albuminuria testing (urine ACR) in people with hypertension or diabetes in primary care? Qualitative interviews or an audit of testing rates.
6. How effectively does the NICE NG203 referral threshold identify people who later progress to kidney failure? Compare the guideline wording with published validation studies.
7. How should a 30-day or 90-day persistence rule for CKD diagnosis be applied when albuminuria results fluctuate? A methods-focused critical review.
8. To what extent do SGLT2 inhibitors slow eGFR decline in non-diabetic CKD, judging by DAPA-CKD and EMPA-KIDNEY? A comparison of two named trials suits a literature review.
9. How do the eligibility criteria of EMPA-KIDNEY and DAPA-CKD limit generalisability to older patients with multimorbidity? Critical appraisal exercise.
10. What is the evidence that CKD prevalence differs between GBD 2023 estimates and national survey estimates in one chosen country? Secondary data; adjust the country to your own.
11. How well do patients with stage 3 CKD understand their diagnosis, and what shapes that understanding? A small survey or interview study with ethics approval.
12. Whether anaemia of CKD management has shifted since the introduction of HIF-PH inhibitors, as shown in published trials and regulatory decisions. Narrative review with a regulatory angle.
Acute Kidney Injury and Critical Care Nephrology Topics
Acute kidney injury (AKI) sits between nephrology, critical care and nursing. Questions on recognition and response are practical and easy to scope.
13. How effective are electronic AKI alerts at improving clinician response, according to published before-and-after studies? Systematic review.
14. To what extent does the KDIGO AKI staging definition agree with urine-output-based criteria in published ICU cohorts? Methodological comparison.
15. What limits the use of biomarkers such as NGAL or TIMP-2 and IGFBP7 in routine AKI diagnosis? Review of diagnostic accuracy studies.
16. How should the timing of renal replacement therapy in critically ill adults be interpreted after the STARRT-AKI and AKIKI trials? Name both trials and compare results.
17. Whether contrast-associated AKI is overestimated in observational studies compared with randomised evidence. Critical appraisal.
18. How far does post-AKI follow-up in primary care match guideline recommendations? Audit-style design; check whether ethics or audit approval applies.
19. What are nurses’ experiences of recognising early AKI on general wards? Qualitative study; see our nursing topics for related ideas.
20. To what extent does AKI during hospital admission increase later CKD risk in published long-term cohorts? Meta-analytic or narrative review.
21. How do sepsis-associated AKI definitions affect reported incidence across studies? Definitions-focused review.
Glomerular Disease Dissertation Topics
Glomerular disease has moved quickly, so many strong topics ask what a newly approved or guideline-endorsed therapy changes in practice. Always state which regulatory stage a treatment has reached.
22. How do the 2021 KDIGO glomerular disease guideline recommendations for IgA nephropathy compare with current clinical practice in the UK? Guideline versus practice comparison.
23. What does the NefIgArd trial of targeted-release budesonide show about proteinuria and eGFR in IgA nephropathy, and what limits its wider use? Single-trial critical appraisal.
24. How far do the PROTECT trial results for sparsentan change the treatment pathway for IgA nephropathy? Check the current regulatory position before writing.
25. Whether supportive care alone is sufficient in low-risk IgA nephropathy: what do the STOP-IgAN and TESTING trials suggest? Compare two named trials.
26. To what extent does the Oxford MEST-C classification predict outcomes in IgA nephropathy across ethnic groups? Literature-based.
27. How should rituximab be positioned against calcineurin inhibitors in primary membranous nephropathy? Review of trial data such as the MENTOR study.
28. What is the evidence for anti-PLA2R antibody monitoring in guiding treatment decisions in membranous nephropathy? Diagnostic and prognostic review.
29. How effectively do steroid-sparing regimens prevent relapse in adult minimal change disease? Systematic review.
30. What limits the diagnosis and treatment of FSGS when genetic and secondary causes are considered? Narrative review with a genetics link.
31. How do the 2024 KDIGO lupus nephritis recommendations on triple therapy differ from earlier guidance? Document analysis.
32. To what extent does belimumab or voclosporin add benefit in lupus nephritis, judging by BLISS-LN and AURORA 1? Compare named trials.
33. How far does the ADVOCATE trial of avacopan support steroid reduction in ANCA-associated vasculitis? Single-trial appraisal.
34. What is known about the incidence and outcomes of C3 glomerulopathy treated with complement inhibitors? Short rare-disease review.
35. How do patients with a rare glomerular disease experience diagnosis delay, and who do they see first? Qualitative; the RaDaR registry context can frame the problem.
The KDIGO guidelines are the standard reference for most topics in this section.
Diabetic Kidney Disease and Cardio-Kidney-Metabolic Topics
Diabetic kidney disease links nephrology to endocrinology and cardiology. Questions that compare drug classes or care pathways are easier to finish within a term.
36. To what extent does finerenone reduce kidney and cardiovascular outcomes in type 2 diabetes, based on FIDELIO-DKD and FIGARO-DKD? Pooled-trial reading, such as the FIDELITY analysis.
37. How far does the CREDENCE trial support canagliflozin for diabetic kidney disease compared with other SGLT2 inhibitors? Class-effect debate.
38. What does the FLOW trial of semaglutide add to kidney protection in type 2 diabetes? Check for guideline updates before writing.
39. How should SGLT2 inhibitors, GLP-1 receptor agonists and finerenone be sequenced in diabetic kidney disease? Narrative synthesis of guidance.
40. Whether people with type 2 diabetes and CKD receive guideline-recommended therapy in practice, according to published prescribing studies. Secondary data review.
41. How well does annual urine ACR screening in diabetes clinics follow national standards? Audit-style; check approval route.
42. What limits patient adherence to a multi-drug kidney-protective regimen? Qualitative or survey design.
43. How does cardiovascular-kidney-metabolic syndrome, as defined by the American Heart Association, change how clinicians describe CKD risk? Concept analysis.
44. To what extent do dietary sodium and protein recommendations in CKD differ between KDIGO and national dietetic guidance? Document comparison.
45. What is the cost-effectiveness evidence for SGLT2 inhibitors in CKD in publicly funded health systems? Pair with our health economics topics.
Dialysis and Vascular Access Dissertation Topics
Dialysis topics suit nursing, public health and health policy projects. Access to patients is sensitive, so many students choose published data or staff-focused designs.
46. To what extent does haemodiafiltration improve survival compared with high-flux haemodialysis, based on the CONVINCE trial? Single-trial appraisal with earlier pooled data.
47. How do home dialysis rates compare between UK centres, using UK Renal Registry reports? Registry data analysis.
48. What limits the uptake of peritoneal dialysis in one chosen health system? Mixed review and interview design.
49. How far does patient-reported experience differ between in-centre haemodialysis and home haemodialysis? Systematic review.
50. Whether incremental dialysis start protects residual kidney function more than a standard start. Evidence review.
51. How effectively do arteriovenous fistula first policies work compared with catheter-based access? Policy and outcome review.
52. What is the evidence on buttonhole versus rope-ladder cannulation and infection risk? Narrow technique review.
53. How should intradialytic hypotension be managed, according to current evidence? Clinical review.
54. To what extent does the PIVOTAL trial shape intravenous iron practice in haemodialysis? Single-trial appraisal.
55. How do dialysis nurses describe their role in shared decision-making about treatment modality? Qualitative; see our nursing dissertation help.
56. What are the environmental costs of haemodialysis, and what has been done to reduce water and plastic use? Sustainability review.
57. How far do transport and travel time affect missed dialysis sessions in published studies? Health services question.
58. Whether travelling dialysis and holiday dialysis are equitably available across regions. Policy and access study.
Need a hand shaping any of these? Our medical dissertation help covers the full project.
Kidney Transplantation Dissertation Topics
Transplantation topics range from immunology to ethics and allocation policy. Where a development is still experimental, state its stage plainly and avoid presenting it as routine care.
59. How effectively does the UK kidney offering scheme balance utility and equity, based on NHSBT reports? Policy and registry analysis.
60. To what extent do ethnic minority patients face longer waits for deceased-donor kidneys in the UK? Use published NHSBT data.
61. How far has the opt-out consent law changed deceased donation rates in the UK? Compare with published donation statistics.
62. Whether normothermic machine perfusion improves graft outcomes compared with static cold storage. Review of trials.
63. What limits living donor kidney transplantation among eligible patients? Barriers review with a social lens.
64. How should kidney paired donation schemes be evaluated for fairness and efficiency? Policy question.
65. To what extent do donor-specific antibodies predict antibody-mediated rejection? Immunology review; link with our immunology topics.
66. How effective are desensitisation protocols for highly sensitised patients? Evidence review.
67. What does the evidence show about belatacept compared with tacrolimus-based immunosuppression? Drug comparison.
68. How far does non-adherence to immunosuppression explain graft loss in adolescents and young adults? Review of adherence studies.
69. What are transplant recipients’ experiences of long-term follow-up and cancer screening? Qualitative; see transplant nursing topics.
70. What do early clinical studies of gene-edited pig kidney xenotransplantation show, and what ethical questions remain? Experimental stage; state this clearly and check the latest reports.
71. How do ethical frameworks justify or limit the use of organs from donors after circulatory death? Ethics project.
72. Whether BK virus screening strategies reduce graft loss after transplantation. Narrow clinical review.
Paediatric Nephrology and Inherited Kidney Disease Topics
Children’s kidney disease and genetic disease give narrow, original topics. Studies involving children need careful ethics, so reviews and registry-based designs are often the safest option.
73. How is congenital anomalies of the kidney and urinary tract (CAKUT) detected antenatally, and how does detection affect outcomes? Review; link with our urology topics.
74. What do the CKiD cohort findings show about growth and neurocognitive outcomes in children with CKD? Cohort-based review.
75. How effective is growth hormone therapy in children with CKD? Evidence review.
76. To what extent does early genetic testing change diagnosis in children with steroid-resistant nephrotic syndrome? Genetics link.
77. How should transition from paediatric to adult kidney services be organised? Service review.
78. What does tolvaptan show about slowing ADPKD progression in the TEMPO 3:4 trial, and what are its limits? Trial appraisal.
79. How far can the Mayo imaging classification predict ADPKD progression? Prognostic review.
80. What is known about the outcomes of Alport syndrome when treatment starts early? Short review.
81. How does APOL1 genotype contribute to kidney disease risk in people of African ancestry? Genetics and inequality review.
82. Whether lumasiran and similar therapies change the management of primary hyperoxaluria. Check the latest regulatory position.
83. What are the psychosocial effects of living with an inherited kidney condition within a family? Qualitative design.
84. How is the ethical balance handled when screening relatives for a late-onset kidney condition? Ethics and genetics.
Onconephrology, Nephrotoxins and Environmental Kidney Disease Topics
These topics sit at the edge of nephrology, pharmacology and public health, which makes them useful for interdisciplinary degrees.
85. How common is kidney injury associated with immune checkpoint inhibitors, and how is it managed? Review of case series and guidance.
86. To what extent does cisplatin nephrotoxicity limit chemotherapy choice, and what protective measures exist? Pharmacology link.
87. What is the kidney risk associated with proton pump inhibitor use in published cohort studies? Critical appraisal of observational evidence.
88. How far do NSAIDs contribute to community-acquired AKI, and how could prescribing be improved? Audit-style or review.
89. What causes CKD of unknown origin among agricultural workers, and which hypotheses have the most support? Public health review.
90. How does heat exposure affect kidney outcomes in outdoor workers? Climate and health topic.
91. Whether air pollution is associated with CKD incidence in large population studies. Environmental epidemiology review.
92. What do the published studies say about herbal remedies and kidney injury? Safety review.
Conservative Kidney Management, Nursing and Patient-Reported Outcomes Topics
These topics fit nursing, palliative care and health psychology projects, and they usually need no clinical data access.
93. How effective is conservative kidney management compared with dialysis for frail older adults, based on published comparisons? Evidence review; see our geriatric nursing topics.
94. What do patients and families say matters most in advance care planning for kidney failure? Qualitative; see palliative care nursing topics.
95. How well are symptoms such as fatigue, pruritus and pain measured in routine kidney care? Measurement review.
96. To what extent do patient-reported outcome measures such as the IPOS-Renal inform clinic decisions? Implementation review.
97. How do renal nurses manage fluid and dietary restrictions with patients, and what makes this hard? Qualitative nursing study.
98. What is the evidence for exercise programmes during dialysis? Intervention review.
99. How does depression screening in dialysis units follow guidance, and what follows a positive result? Service evaluation.
100. Whether peer support improves self-management in people with CKD. Review of interventions.
101. How do health literacy and language barriers shape decisions about kidney replacement therapy? Inequality and communication topic.
Health Inequalities, Global Kidney Care and AI in Nephrology Topics
Global and digital topics are popular for master’s and doctoral work. Use international sources alongside UK data, and adjust the country to your own context rather than writing separate topics for each.
102. How do the ISN Global Kidney Health Atlas findings describe access to dialysis and transplantation across income groups? Secondary data.
103. To what extent does socioeconomic deprivation explain differences in CKD progression and dialysis start in the UK? Registry-based.
104. What is the evidence on kidney health outcomes for refugees and migrants? Equity review.
105. How feasible is kidney care delivery in low-resource settings, and which models have worked? Health systems review.
106. How accurate are machine learning models for predicting AKI in hospital, and how are they validated? Link with our AI dissertation topics.
107. Whether AI tools applied to kidney biopsy images improve diagnostic agreement among pathologists. Review; link with pathology topics.
108. What are the ethical and data governance concerns when using routine kidney data for algorithm development? Governance and law.
109. How do telehealth and remote monitoring change outcomes for people on home dialysis? Digital health review.
Worked Examples: From Topic to Aim and Objectives
A topic becomes a proposal when it has one aim and two or three objectives. Three examples show the pattern.
Example 1: Kidney Failure Risk Equation in Primary Care (Master’s)
Aim: to evaluate how well the KFRE predicts kidney failure compared with eGFR staging in published primary care cohorts. Objectives: (1) identify validation studies of the KFRE; (2) compare reported discrimination and calibration; (3) discuss how the findings affect referral thresholds under NICE NG203.
Example 2: Home Dialysis Uptake Across UK Centres (Master’s)
Aim: to describe variation in home dialysis use across UK kidney centres. Objectives: (1) extract centre-level modality data from UK Kidney Association reports; (2) compare rates across regions; (3) discuss reasons for variation reported in the literature.
Example 3: Nurses’ Experiences of Early AKI Recognition (Undergraduate)
Aim: to explore how ward nurses recognise early AKI. Objectives: (1) interview a small purposive sample; (2) identify barriers to recognition; (3) suggest practical changes to training. This needs ethics approval before recruitment.
Methods and Level Guidance for a Nephrology Dissertation
Undergraduate projects work best as focused literature reviews or small qualitative studies. Master’s projects can use registry data, systematic review methods or an audit-style design. Doctoral work needs a distinct contribution, such as a new analysis of a registry or a mixed-methods study. Our dissertation methodology help and statistical test selector help you pick a design, and the sample size calculator helps if you collect primary data.
For international sources, use ISN Global Kidney Health Atlas, USRDS and Global Burden of Disease data alongside UK sources. The NICE CKD guideline NG203 is the main UK clinical reference. Adjust any topic to your own country by swapping in that country’s registry or guideline.
Before you write the literature chapter, read our literature review help guide, and use the research question generator or the aims and objectives generator to tidy your wording.
Related Medical Dissertation Topics
Nephrology overlaps with several subjects. Explore cardiology dissertation topics, immunology dissertation topics, transplant nursing dissertation topics and pharmacology dissertation topics. If you want broader ideas, see our medicine dissertation topics.
Frequently Asked Questions
Can I use these nephrology topics for free?
Yes. All topics, ideas and titles on this page are 100% free to use and adapt.
Which nephrology topic is easiest without patient access?
Registry-based and literature-review topics, such as those on KFRE validation, transplant allocation or SGLT2 inhibitor trials, need no patient contact.
Do I need ethics approval for a nephrology project?
It depends on your design and your university. Reviews of published work usually do not, while interviews with patients or staff usually do. Check with your supervisor and the HRA decision tool.